All In Biotech

Drug Trial Radar · NCT02105493

Nitroglycerin Prevents Radial Artery Occlusion

A Novel Approach to Reduce Radial Artery Occlusion After Trans-Radial Catheterization: Post-Procedural/Pre-Hemostasis Intra-Arterial Nitroglycerin

Last checked: Nov 19, 2026Latest source record: Apr 7, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,706 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,706

Actual

Start

Oct 2013

Primary completion

Feb 2014

Study completion Mar 2014

Sponsor

Sponsor type
Academic, hospital or other
First posted
Apr 7, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Prevention
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Trans-radial approach (TRA) has becoming popular and widely adopted over the last decade. However, radial artery occlusion (RAO) continues to be one of the limitation of trans-radial access and potentially limits the radial artery as an access site in the future. Several strategies have been used to decrease the incidence of RAO including the use of anticoagulation, maintenance of patency during hemostasis, or shortening the duration of compression. Currently, there is no data whether vasoactive pharmacological therapy such as nitroglycerin administered intra-arterially at the end of the procedure may reduce the incidence of RAO. It is hypothesized that the addition of nitroglycerin (nitric oxide donor) at the end of a TRA procedure may reduce the incidence of RAO.

Conditions

  • Injury of Radial Artery

Interventions

  • 500 microgram of NitroglycerinDrug

    500 microgram of Nitroglycerin (in 5 mL saline) given intra-arterially through the sheath at the end of transradial procedure

  • Saline 5 mLDrug

    Saline 5 mL given intra-arterially through the sheath at the end of transradial procedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of radial artery occlusion as confirmed by absence of antegrade flow in vascular high resolution ultrasoundTime frame: One Day After the Index Procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Cardiovascular Center Harapan Kita

    Jakarta, Jakarta Special Capital Region, Indonesia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.